These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11352969)

  • 1. Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
    Lawrence JA; Adamson PC; Caruso R; Chow C; Kleiner D; Murphy RF; Venzon DJ; Shovlin M; Noone M; Merino M; Cowan KH; Kaiser M; O'Shaughnessy J; Zujewski J
    J Clin Oncol; 2001 May; 19(10):2754-63. PubMed ID: 11352969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.
    Toma S; Raffo P; Nicolo G; Canavese G; Margallo E; Vecchio C; Dastoli G; Iacona I; Regazzi-Bonora M
    Int J Oncol; 2000 Nov; 17(5):991-1000. PubMed ID: 11029503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
    Sutton LM; Warmuth MA; Petros WP; Winer EP
    Cancer Chemother Pharmacol; 1997; 40(4):335-41. PubMed ID: 9225952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
    Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
    Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
    Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM
    Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study.
    Miller WH; Reyno LM; Loewen GR; Huan S; Winquist E; Moore M; Cato A; Jaunakais D; Truglia JA; Matthews S; Dancey J; Eisenhauer E
    Ann Oncol; 2000 Nov; 11(11):1387-9. PubMed ID: 11142476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.
    Lebowitz PF; Eng-Wong J; Widemann BC; Balis FM; Jayaprakash N; Chow C; Clark G; Gantz SB; Venzon D; Zujewski J
    Clin Cancer Res; 2005 Feb; 11(3):1247-52. PubMed ID: 15709195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
    J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.
    Wadler S; Schwartz EL; Anderson P; Runowicz CD; Chuang L; Del Priore G; Hochster H; Goldberg G; Fields A; Loewen G; Haynes H
    Cancer J Sci Am; 1999; 5(3):165-70. PubMed ID: 10367173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
    Toffoli G; Sorio R; Aita P; Crivellari D; Corona G; Bearz A; Robieux I; Colussi AM; Stocco F; Boiocchi M
    Clin Cancer Res; 2000 Jun; 6(6):2279-87. PubMed ID: 10873078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
    Esteva FJ; Glaspy J; Baidas S; Laufman L; Hutchins L; Dickler M; Tripathy D; Cohen R; DeMichele A; Yocum RC; Osborne CK; Hayes DF; Hortobagyi GN; Winer E; Demetri GD
    J Clin Oncol; 2003 Mar; 21(6):999-1006. PubMed ID: 12637463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study.
    Hofmann WK; Kell WJ; Fenaux P; Castaigne S; Ganser A; Chomienne C; Burnett R; Kowal C; Hoelzer D; Burnett AK
    Leukemia; 2000 Sep; 14(9):1583-8. PubMed ID: 10995004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    O'connor T; Rustum Y; Levine E; Creaven P
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):125-31. PubMed ID: 17426973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-aminocamptothecin in a colloidal dispersion formulation in patients with advanced solid tumors.
    Herben VM; van Gijn R; Schellens JH; Schot M; Lieverst J; Hillebrand MJ; Schoemaker NE; Porro MG; Beijnen JH; ten Bokkel Huinink WW
    J Clin Oncol; 1999 Jun; 17(6):1906-14. PubMed ID: 10561232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).
    Fumoleau P; Koch KM; Brain E; Lokiec F; Rezai K; Awada A; Hayward L; Werutsky G; Bogaerts J; Marréaud S; Cardoso F
    Breast; 2014 Oct; 23(5):663-9. PubMed ID: 25065668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
    Park SH; Gray WC; Hernandez I; Jacobs M; Ord RA; Sutharalingam M; Smith RG; Van Echo DA; Wu S; Conley BA
    Clin Cancer Res; 2000 Mar; 6(3):847-54. PubMed ID: 10741706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of imexon in patients with advanced malignancy.
    Dragovich T; Gordon M; Mendelson D; Wong L; Modiano M; Chow HH; Samulitis B; O'Day S; Grenier K; Hersh E; Dorr R
    J Clin Oncol; 2007 May; 25(13):1779-84. PubMed ID: 17470869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
    Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.